| Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms F Panza, V Frisardi, C Capurso, BP Imbimbo, G Vendemiale, A Santamato, ... Journal of Alzheimer's disease 21 (3), 691-724, 2010 | 199 | 2010 |
| Apigenin as neuroprotective agent: Of mice and men SF Nabavi, H Khan, G D'onofrio, D Šamec, S Shirooie, AR Dehpour, ... Pharmacological research 128, 359-365, 2018 | 189 | 2018 |
| Mediterranean diet in predementia and dementia syndromes V Solfrizzi, V Frisardi, D Seripa, G Logroscino, B P Imbimbo, G D'Onofrio, ... Current Alzheimer Research 8 (5), 520-542, 2011 | 146 | 2011 |
| Targeting NF-κB signaling pathway in cancer by dietary polyphenols H Khan, H Ullah, PCMF Castilho, AS Gomila, G D'Onofrio, R Filosa, ... Critical Reviews in Food Science and Nutrition 60 (16), 2790-2800, 2020 | 124 | 2020 |
| The genetics of the human APOE polymorphism D Seripa, G D'Onofrio, F Panza, L Cascavilla, C Masullo, A Pilotto Rejuvenation research 14 (5), 491-500, 2011 | 116 | 2011 |
| Oral microbiota and Alzheimer’s disease: Do all roads lead to Rome? A Sureda, M Daglia, SA Castilla, N Sanadgol, SF Nabavi, H Khan, ... Pharmacological research 151, 104582, 2020 | 113 | 2020 |
| The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short-and long-term mortality in hospitalized older patients with dementia A Pilotto, D Sancarlo, F Panza, F Paris, G D'Onofrio, L Cascavilla, ... Journal of Alzheimer's disease 18 (1), 191-199, 2009 | 113 | 2009 |
| Caregiver burden characterization in patients with Alzheimer's disease or vascular dementia G D'Onofrio, D Sancarlo, F Addante, F Ciccone, L Cascavilla, F Paris, ... International journal of geriatric psychiatry 30 (9), 891-899, 2015 | 112 | 2015 |
| Neuropsychiatric symptoms and functional status in Alzheimer’s disease and vascular dementia patients G D’Onofrio, D Sancarlo, F Panza, M Copetti, L Cascavilla, F Paris, ... Current Alzheimer Research 9 (6), 759-771, 2012 | 109 | 2012 |
| Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? BP Imbimbo, F Panza, V Frisardi, V Solfrizzi, G D'Onofrio, G Logroscino, ... Expert opinion on investigational drugs 20 (3), 325-341, 2011 | 109 | 2011 |
| The multidimensional prognostic index predicts short-and long-term mortality in hospitalized geriatric patients with pneumonia A Pilotto, F Addante, L Ferrucci, G Leandro, G D’Onofrio, M Corritore, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2009 | 107 | 2009 |
| Different models of frailty in predementia and dementia syndromes F Panza, V Solfrizzi, V Frisardi, S Maggi, D Sancarlo, F Addante, ... The Journal of nutrition, health and aging 15 (8), 711-719, 2011 | 104 | 2011 |
| Metabolic syndrome, mild cognitive impairment and dementia F Panza, V Frisardi, D Seripa, B P Imbimbo, D Sancarlo, G D'Onofrio, ... Current Alzheimer Research 8 (5), 492-509, 2011 | 98 | 2011 |
| Information and communication technologies for the activities of daily living in older patients with dementia: a systematic review G D’Onofrio, D Sancarlo, F Ricciardi, F Panza, D Seripa, F Cavallo, ... Journal of Alzheimer's Disease 57 (3), 927-935, 2017 | 92 | 2017 |
| Information and communication technology systems to improve quality of life and safety of Alzheimer's disease patients: a multicenter international survey A Pilotto, G D'Onofrio, E Benelli, A Zanesco, A Cabello, MC Margelí, ... Journal of Alzheimer's Disease 23 (1), 131, 2011 | 89 | 2011 |
| Validation of a Modified-Multidimensional Prognostic Index (m-MPI) including the Mini Nutritional Assessment Short-Form (MNA-SF) for the prediction of one-year mortality in … D Sancarlo, G D'Onofrio, M Franceschi, C Scarcelli, V Niro, F Addante, ... The Journal of nutrition, health and aging 15 (3), 169-173, 2011 | 81 | 2011 |
| The RELN locus in Alzheimer's disease D Seripa, MG Matera, M Franceschi, A Daniele, A Bizzarro, M Rinaldi, ... Journal of Alzheimer's Disease 14 (3), 335-344, 2008 | 81 | 2008 |
| Bapineuzumab: Anti-β-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer‘s Disease F Panza, V Frisardi, BP Imbimbo, G D ‘Onofrio, G Pietrarossa, D Seripa, ... Immunotherapy 2 (6), 767-782, 2010 | 77 | 2010 |
| Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review Q Ruan, G D’Onofrio, D Sancarlo, Z Bao, A Greco, Z Yu BMC geriatrics 16, 1-9, 2016 | 76 | 2016 |
| Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease D Seripa, A Bizzarro, A Pilotto, G D'onofrio, G Vecchione, AP Gallo, ... Pharmacogenetics and genomics 21 (4), 225-230, 2011 | 74 | 2011 |
